Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birol Emir

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Current Medical Research and Opinion|December 24, 2015
The safety and efficacy of pregabalin for treating subjects with fibromyalgia and moderate or severe baseline widespread painAndrew Clair, Birol Emir
Journal of Diabetes and Its Complications|August 18, 2016
Glycemic and serum lipid control in patients with painful diabetic peripheral neuropathy treated with pregabalinBruce Parsons, Birol Emir
Journal of Pain Research|June 18, 2015
Predictors of placebo response in peripheral neuropathic pain: insights from pregabalin clinical trialsRoy Freeman, Birol Emir, Bruce Parsons
American Journal of Therapeutics|October 2, 2014
Examining the Time to Improvement of Sleep Interference With Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy and Postherpetic NeuralgiaBruce Parsons, Birol Emir, Lloyd Knapp
Journal of Pain Research|July 15, 2015
Temporal analysis of pain responders and common adverse events: when do these first appear following treatment with pregabalinBruce Parsons, Birol Emir, Andrew Clair
Clinical Therapeutics|April 9, 2015
Examining the Time to Therapeutic Effect of Pregabalin in Spinal Cord Injury Patients With Neuropathic PainDiana D Cardenas, Birol Emir, Bruce Parsons
Diabetes Care|March 22, 2008
Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of dosesRoy Freeman, Edith Durso-Decruz, Birol Emir
Clinical Therapeutics|April 2, 2013
Relationship between pain relief and improvements in patient function/quality of life in patients with painful diabetic peripheral neuropathy or postherpetic neuralgia treated with pregabalinAaron Vinik, Birol Emir, Raymond Cheung, et al.
Current Medical Research and Opinion|July 2, 2013
Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerabilityStuart Montgomery, Birol Emir, Hannah Haswell, et al.
Journal of Clinical Epidemiology|May 10, 2025
Beyond the binary: integrating "real-world evidence" with randomized trials in contemporary health careDeclan Devane, Birol Emir, Stephen Watt, et al.
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Current Medical Research and Opinion|December 24, 2015
The safety and efficacy of pregabalin for treating subjects with fibromyalgia and moderate or severe baseline widespread painAndrew Clair, Birol Emir
Journal of Diabetes and Its Complications|August 18, 2016
Glycemic and serum lipid control in patients with painful diabetic peripheral neuropathy treated with pregabalinBruce Parsons, Birol Emir
Journal of Pain Research|June 18, 2015
Predictors of placebo response in peripheral neuropathic pain: insights from pregabalin clinical trialsRoy Freeman, Birol Emir, Bruce Parsons
American Journal of Therapeutics|October 2, 2014
Examining the Time to Improvement of Sleep Interference With Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy and Postherpetic NeuralgiaBruce Parsons, Birol Emir, Lloyd Knapp
Journal of Pain Research|July 15, 2015
Temporal analysis of pain responders and common adverse events: when do these first appear following treatment with pregabalinBruce Parsons, Birol Emir, Andrew Clair
Clinical Therapeutics|April 9, 2015
Examining the Time to Therapeutic Effect of Pregabalin in Spinal Cord Injury Patients With Neuropathic PainDiana D Cardenas, Birol Emir, Bruce Parsons
Diabetes Care|March 22, 2008
Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of dosesRoy Freeman, Edith Durso-Decruz, Birol Emir
Clinical Therapeutics|April 2, 2013
Relationship between pain relief and improvements in patient function/quality of life in patients with painful diabetic peripheral neuropathy or postherpetic neuralgia treated with pregabalinAaron Vinik, Birol Emir, Raymond Cheung, et al.
Current Medical Research and Opinion|July 2, 2013
Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerabilityStuart Montgomery, Birol Emir, Hannah Haswell, et al.
Journal of Clinical Epidemiology|May 10, 2025
Beyond the binary: integrating "real-world evidence" with randomized trials in contemporary health careDeclan Devane, Birol Emir, Stephen Watt, et al.
Pageof 11